As indicated in Fig. 2a and Supplementary Fig. 2a, tumor volumes were markedly decreased by more than ~36% and 47%, compared to those in the control siRNA group, in the PLOD3 siRNA-treated group and radiation-treated group, respectively. This evidence concerns the gene PLOD3 and neoplasm.